Skip to content

Exagen Inc. XGN Other Income (Expense)

Other Income (Expense) at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
-$13.1M-1,210%
Quest Diagnostics logo
Quest DiagnosticsDGX
-$65M+7.1%
Vor Biopharma logo
Vor BiopharmaVOR
-$184.43M-23,010%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$1.28M-16.0%
CareDx logo
CareDxCDNA
$1.58M-48.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$24.2M-34.9%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s other income (expense)?
Exagen Inc. (XGN) reported other income (expense) of -$132K in Q1 2026.
How has Exagen Inc.'s other income (expense) changed year-over-year?
Exagen Inc.'s other income (expense) decreased by 183.5% year-over-year, from $158K to -$132K.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.